CRISPR/Cas9 gene editing as well as use of RTK inhibitor sunitinib of VEGFR2/KDR significantly disrupted thyroid cell cycle regulation, cell growth, and downstream signal transduction, resulting in decreased colony formation and invasion abilities. This evidence concerns the gene KDR and thyroid gland disorder.